Multispectral imaging reveals the tissue distribution of tetraspanins in human lymphoid organs

Histochemistry and Cell Biology

Volumn 144, Issue 2, 2015, Pages 133-146

  de Winde, Charlotte M ^a   Zuidscherwoude, Malou ^a   Vasaturo, Angela ^a   van der Schaaf, Alie ^a   Figdor, Carl G ^a   van Spriel, Annemiek B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CD37; CD53; Immune system; Multispectral imaging; Tetraspanin

Indexed keywords

CD37 ANTIGEN; CD53 ANTIGEN; TETRASPANIN; CD37 PROTEIN, HUMAN; CD53 PROTEIN, HUMAN; TUMOR ANTIGEN;

APPENDIX; ARTICLE; B LYMPHOCYTE; BONE MARROW; CD3+ T LYMPHOCYTE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOSOME; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGING AND DISPLAY; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INVESTIGATIVE PROCEDURES; LYMPHOID ORGAN; LYSOSOME; MICROSCOPY; MULTISPECTRAL IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SPLEEN; TISSUE DISTRIBUTION; BIOSYNTHESIS; CHEMISTRY; CONFOCAL MICROSCOPY; CYTOLOGY; LYMPHOID TISSUE; METABOLISM;

ANTIGENS, CD53; ANTIGENS, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOID TISSUE; MICROSCOPY, CONFOCAL; SPLEEN; TETRASPANINS;

EID: 84938415242     PISSN: 09486143     EISSN: 1432119X     Source Type: Journal    
DOI: 10.1007/s00418-015-1326-2     Document Type: Article

References (36)

1. Barrena S, Almeida J, Yunta M et al (2005) Aberrant expression of tetraspanin molecules in B-cell chronic lymphoproliferative disorders and its correlation with normal B-cell maturation. Leukemia 19:1376–1383. doi:10.1038/sj.leu.2403822
2. Berditchevski F, Odintsova E (2007) Tetraspanins as regulators of protein trafficking. Traffic 8:89–96
3. Canene-Adams K (2013) Preparation of formalin-fixed paraffin-embedded tissue for immunohistochemistry. In: Lorsch J (ed) Methods enzymology. Academic Press, Waltham, pp 225–233
4. Charrin S, Jouannet S, Boucheix C, Rubinstein E (2014) Tetraspanins at a glance. J Cell Sci. doi:10.1242/jcs.154906
5. Escola JM, Kleijmeer MJ, Stoorvogel W et al (1998) Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem 273:20121–20127
6. Gartlan KH, Belz GT, Tarrant JM et al (2010) A complementary role for the tetraspanins CD37 and Tssc6 in cellular immunity. J Immunol 185:3158–3166. doi:10.4049/jimmunol.0902867
7. Gartlan KH, Wee JL, Demaria MC et al (2013) Tetraspanin CD37 contributes to the initiation of cellular immunity by promoting dendritic cell migration. Eur J Immunol 43:1208–1219. doi:10.1002/eji.201242730
8. Hemler ME (2005) Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol 6:801–811
9. Hemler ME (2014) Tetraspanin proteins promote multiple cancer stages. Nat Rev Cancer 14:49–60
10. Junt T, Scandella E, Ludewig B (2008) Form follows function: lymphoid tissue microarchitecture in antimicrobial immune defence. Nat Rev Immunol 8:764–775. doi:10.1038/nri2414
11. Knobeloch KP, Wright MD, Ochsenbein AF et al (2000) Targeted inactivation of the tetraspanin CD37 impairs T-cell-dependent B-cell response under suboptimal costimulatory conditions. Mol Cell Biol 20:5363–5369
12. Kobayashi T, Vischer UM, Rosnoblet C et al (2000) The tetraspanin CD63/lamp3 cycles between endocytic and secretory compartments in human endothelial cells. Mol Biol Cell 11:1829–1843
13. Kraft S, Jouvin M-H, Kulkarni N et al (2013) The tetraspanin CD63 is required for efficient IgE-mediated mast cell degranulation and anaphylaxis. J Immunol 191:2871–2878. doi:10.4049/jimmunol.1202323
14. Lapalombella R, Yeh YY, Wang L et al (2012) Tetraspanin CD37 directly mediates transduction of survival and apoptotic signals. Cancer Cell 21:694–708. doi:10.1016/j.ccr.2012.03.040
15. Mansfield JR (2010) Cellular context in epigenetics: quantitative multicolor imaging and automated per-cell analysis of miRNAs and their putative targets. Methods 52:271–280. doi:10.1016/j.ymeth.2010.10.001
16. Månsson R, Lagergren A, Hansson F et al (2007) The CD53 and CEACAM-1 genes are genetic targets for early B cell factor. Eur J Immunol 37:1365–1376. doi:10.1002/eji.200636642
17. Meyer-Wentrup F, Figdor CG, Ansems M et al (2007) Dectin-1 interaction with tetraspanin CD37 inhibits IL-6 production. J Immunol 178:154–162
18. Mollinedo F, Fontán G, Barasoain I, Lazo PA (1997) Recurrent infectious diseases in human CD53 deficiency. Clin Diagn Lab Immunol 4:229–231
19. Puls KL, Hogquist KA, Reilly N, Wright MD (2002) CD53, a thymocyte selection marker whose induction requires a lower affinity TCR-MHC interaction than CD69, but is up-regulated with slower kinetics. Int Immunol 14:249–258
20. Rafiq S, Siadak A, Butchar JP et al (2013) Glycovariant anti-CD37 monospecific protein therapeutic exhibits enhanced effector cell-mediated cytotoxicity against chronic and acute B cell malignancies. MAbs 5:723–735. doi:10.4161/mabs.25282
21. Robak T, Robak P, Smolewski P (2009) TRU-016, a humanized anti-CD37 IgG fusion protein for the potential treatment of B-cell malignancies. Curr Opin Investig Drugs 10:1383–1390
22. Roozendaal R, Mebius RE, Kraal G (2008) The conduit system of the lymph node. Int Immunol 20:1483–1487. doi:10.1093/intimm/dxn110
23. Rubinstein E, Le Naour F, Lagaudriere-Gesbert C et al (1996) CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur J Immunol 26:2657–2665
24. Schindelin J, Arganda-Carreras I, Frise E et al (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676–682. doi:10.1038/nmeth.2019
25. Sheng KC, van Spriel AB, Gartlan KH et al (2009) Tetraspanins CD37 and CD151 differentially regulate Ag presentation and T-cell co-stimulation by DC. Eur J Immunol 39:50–55. doi:10.1002/eji.200838798
26. Stack EC, Wang C, Roman KA, Hoyt CC (2014) Multiplexed immunohistochemistry, imaging, and quantitation: a review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis. Methods. doi:10.1016/j.ymeth.2014.08.016
27. Takeda Y, He P, Tachibana I et al (2008) Double deficiency of tetraspanins CD9 and CD81 alters cell motility and protease production of macrophages and causes chronic obstructive pulmonary disease-like phenotype in mice. J Biol Chem 283:26089–26097. doi:10.1074/jbc.M801902200
28. Van Der Loos CM (2010) Chromogens in multiple immunohistochemical staining used for visual assessment and spectral imaging: the colorful future. J Histochem 33:31–40. doi:10.1179/his.2010.33.1.31
29. Van Spriel AB, Puls KL, Sofi M et al (2004) A regulatory role for CD37 in T cell proliferation. J Immunol 172:2953–2961
30. Van Spriel AB, Sofi M, Gartlan KH et al (2009) The tetraspanin protein CD37 regulates IgA responses and anti-fungal immunity. PLoS Pathog 5:e1000338. doi:10.1371/journal.ppat.1000338
31. Van Spriel AB, de Keijzer S, van der Schaaf A et al (2012) The tetraspanin CD37 orchestrates the alpha(4)beta(1) integrin-Akt signaling axis and supports long-lived plasma cell survival. Sci Signal 5:ra82. doi:10.1126/scisignal.2003113
32. Xu C, Zhang YH, Thangavel M et al (2009) CD82 endocytosis and cholesterol-dependent reorganization of tetraspanin webs and lipid rafts. Faseb J 23:3273–3288
33. Yanez-Mo M, Barreiro O, Gordon-Alonso M et al (2009) Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes. Trends Cell Biol 19:434–446
34. Zhang XA, Bontrager AL, Hemler ME (2001) Transmembrane-4 superfamily proteins associate with activated protein kinase C (PKC) and link PKC to specific beta(1) integrins. J Biol Chem 276:25005–25013
35. Zhao X, Lapalombella R, Joshi T et al (2007) Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical. Blood 110:2569–2577. doi:10.1182/blood-2006-12-062927
36. Zuidscherwoude M, de Winde CM, Cambi A, van Spriel AB (2014) Microdomains in the membrane landscape shape antigen-presenting cell function. J Leukoc Biol 95:251–263. doi:10.1189/jlb.0813440